Form 8-K - Current report:
SEC Accession No. 0001213900-15-007254
Filing Date
2015-09-24
Accepted
2015-09-24 15:51:37
Documents
3
Period of Report
2015-09-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k092215_immucellcorp.htm 8-K 16740
2 MORTGAGE LOAN NOTE OF IMMUCELL CORPORATION DATED SEPTEMBER 21, 2015 f8k092215ex99i_immucellcorp.htm EX-99.1 45700
3 AMENDED AND RESTATED LOAN AGREEMENT DATED SEPTEMBER 21, 2015 f8k092215ex99ii_immucellcorp.htm EX-99.2 25513
  Complete submission text file 0001213900-15-007254.txt   89120
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 151123108
SIC: 2835 In Vitro & In Vivo Diagnostic Substances